Evidence map›Paper›PMID 42028016›Full record

ArticleiScience2026

Identification of potential therapeutic target

Fuji Deng, Zhixiang Yan, Jinpeng Li, Longwang Wu, Yong Liu, Yuli Yang

Abstract read
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fuji DengSouthwest Hospital/Southwest Eye Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Zhixiang YanSouthwest Hospital/Southwest Eye Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Jinpeng LiSchool of Computer Science and Technology, Chongqing University, Chongqing, China.
Longwang WuSouthwest Hospital/Southwest Eye Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Yong LiuSouthwest Hospital/Southwest Eye Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Yuli YangSouthwest Hospital/Southwest Eye Hospital, Third Military Medical University (Army Medical University), Chongqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fuchs' endothelial corneal dystrophy (FECD) is a genetic eye disorder that often requires corneal transplantation and lacks targeted therapies. This study aimed to identify new biomarkers and mechanisms of FECD progression. We integrated three GEO corneal endothelial datasets to find consistently differentially expressed genes (DEGs) and constructed a protein-protein interaction (PPI) network to identify hub genes. The identified genes were validated using single-cell RNA sequencing (scRNA-seq) in a rat endothelial injury and endothelial-to-mesenchymal transition (EndMT) model. A competing endogenous RNA (ceRNA) network was predicted using multiple bioinformatics databases. Among 24 common DEGs, Secreted Phosphoprotein 1 (

Indexed as

genomicsmolecular biologyophthalmology

Identifiers

PMID42028016
PMCPMC13099362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.